Asymptomatic carriers of the C9orf72 mutation in ALS/FTD exhibit white matter structural changes and cognitive decline that precede symptomatic disease onset, suggesting this is a neurodevelopmental disorder (Lulé et al., 2020). The gene discussed is C9orf72; the disease is amyotrophic lateral sclerosis.